Shuwen Liu

59PUBLICATIONS
74CO-AUTHORS
Major global burdens of diseaseRegenerative medicine (incl. stem cells)Evolutionary computationCardiology (incl. cardiovascular diseases)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (59)

|Aug 06, 2026
Potent Inhibition of Dengue Virus Infection by Synthetic Compound TXD-174 Through Specific Targeting of IL-24.

|Jul 28, 2026
Resveratrol Ameliorated Hyperlipidemia: Association with Modulation of the Gut Microbiota and Bile Acid Metabolism.

|Jun 10, 2026
TXD-198 Exhibits Inhibitory Activity Against SARS-CoV-2 by Upregulating ANO1.

|Jun 01, 2026
Efavirenz Mitigates Dyslipidemia and Attenuates Ulcerative Colitis through Gut Microbiota Modulation.

|May 19, 2026
Caspase Recruitment Domain 6 (CARD6) is the therapeutic target of dihydroartemisinin for lupus nephritis based on Proteolysis Targeting Chimera (PROTAC) technology.

|Apr 27, 2026
Sorting Nexin 10 Mediates Endosomal Acidification and Autophagy to Promote Influenza A Virus Infection.

Pageof 10

Frequent Collaborators

6 joint publications

Yingfeng Tu

5 joint publications

Shibo Jiang

5 joint publications

Xingang Yao

4 joint publications

Jianjun Chen